4'-C-Methyl-4-deoxyuridine manufacturers
|
| | 4'-C-Methyl-4-deoxyuridine Basic information |
| Product Name: | 4'-C-Methyl-4-deoxyuridine | | Synonyms: | 4'-C-Methyl-4-deoxyuridine;4’-C-Methyl-4-deoxyuridine;1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-5-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one | | CAS: | 1064364-21-1 | | MF: | C10H14N2O5 | | MW: | 242.23 | | EINECS: | | | Product Categories: | | | Mol File: | 1064364-21-1.mol |  |
| | 4'-C-Methyl-4-deoxyuridine Chemical Properties |
| Boiling point | 479.5±55.0 °C(Predicted) | | density | 1.59±0.1 g/cm3(Predicted) | | pka | 13.49±0.70(Predicted) |
| | 4'-C-Methyl-4-deoxyuridine Usage And Synthesis |
| Uses | 4’-C-Methyl-4-deoxyuridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 4'-C-Methyl-4-deoxyuridine Preparation Products And Raw materials |
|